We examined a prototype of the "Ektachem GLU/BUN Analyzer" (Eastman Kodak Co., Rochester, NY 14650) in an extended clinical trial, using the FDA hexokinase reference method and Beckman System I GLU/BUN Analyzer as the selected comparative methods. Sera from 560 patients with various pathological conditions were analyzed by all three methods and the results considered with respect to both the nature of the illness and the treatment being received by the patients.
Next 
Materials, Methods, and Protocols

Description of instrument functions:
The Ektachem GLU/BUN Analyzer (hereafter called simply the "Ektachem") utilizes new principles in chemical analysis ( Figure  1 ). Reagents in a matrix of hydrophilic polymer are coated on top of a transparent polyester base (2). On top of the reagent layers, a white isotropically porous polymer layer, the "spreading layer," is coated, which controls the spread of drops of body fluids to be analyzed. Accordingly, the assay is sensitive to sample viscosity. The analysis for glucose is based on oxidation of glucose, catalyzed by glucose oxidase (EC 1.1.3.4), followed by oxidative coupling, catalyzed by peroxidase (EC 1.11.1.7). For the phenol used in the well-known Trinder reaction (3) is substituted 1,7-dihydroxynaphthalene. 
Evaluation of precision:
We followed the NCCLS "Abbreviated Precision Protocol" (1), using 20, 30, and 100 tL of lyophilized commercial sera, which were reconstituted daily. The entire protocol representing one analytical run was repeated three times (once for each sample volume) in the morning and three times in the afternoon each day. A total of 120 runs was performed on 20 separate days. The 20 working days were grouped into four groups of five consecutive days. The instrument was calibrated before each run. Degrees of freedom = 20.
Results and Discussion
Mean value of 80 determinations.
(1). Tables  5 and 6 is presented to provide the reader a point of reference as to the precision and accuracy of the comparison methods in our hands. Both the reference and Ektachem methods had higher run-to-run variability than within-run variability. The within-run variability of the System I was, however, higher than its run-to-run variability.
The results of the methodcomparison study with use of patients' samples are presented 
Recovery and linearity:
The information presented in Figure 3 demonstrates that the Ektachem glucose analysis is linear at least up to 5860 mg/L.
Specificity:
The specificity of the glucose determination was estimated by testing the effect of 19 potential interferants on the accuracy of serum glucose determinations ( Probability of x and y mean values being equal. Upper 95% confidence limit for the bias.
Identical patient samples were analyzed, at the same time, by all three methods. Sample volume 300 L. Number of patient samples 561.
The effects of various sample sizes and the effect of anticoagulant (2000 mg/L potassium oxalate and 25000 mg/L sodium fluoride) on the systematic analytical error of Ektachem (Table 9) The height of the regression lines-that is, the mean Ektachem (7) values-differ significantly from one sample size to the other in both serum (F = 5.07, p = 0.007) and plasma (F = 15.27, p = 0.001).
The effect of sample volume on precision and accuracy was estimated by placing various different volumes of the same sample into the sample cups. The regular routine of our investigation was designed to follow NCCLS protocols and, when possible, to follow also the routine of a clinical chemistry laboratory.
An NCCLS abbreviated precision protocol took about 90 mm to complete from sample preparation to the analysis of the last sample. We believe that sample evaporation probably was responsible for the following three observations. First, the mean concentration of glucose increased as sample volume decreased during our precision studies (Table 3) . Second, the total random error, when analyzing variance components, was found to increase (Table 3) with decreasing sample volume. This increase in random error could be due to a higher concentration of glucose, in identical samples, toward the end of an analytical run. Third, the glucose concentration of patient samples reported by Ektachem on 20-or 30-tL samples was statistically significantly higher than that of 100-tL samples ( Table 9 ).
The problem of evaporation is not unique to Ektachem. The 
Acceptability
We chose the statistical methods presented by Westgard et al. (8, 11) to assess acceptability.
We calculated random error from the NCCLS precision protocols, using total variability as a measure of random error. Data obtained from method comparison by analysis of patients' samples was used to estimate systematic analytical error. 
